REATA PHARMACEUTICALS

reata-pharmaceuticals-logo

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases. It offers antioxidant inflammation-modulating drugs, as well as drugs that correct protein misfolding. The company also develops drugs for the treatment of renal/cardiovascular and autoimmune diseases. The company was formerly known as Reata Discovery, Inc. and changed its name to Reata Pharmaceuticals, Inc. in May 2005. The company was founded in 2002 and is based in Irving, Texas.

#SimilarOrganizations #People #Financial #Website #More

REATA PHARMACEUTICALS

Social Links:

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2002-01-01

Address:
Irving, Texas, United States

Country:
United States

Website Url:
http://www.reatapharma.com

Total Employee:
51+

Status:
Active

Contact:
972-865-2219

Email Addresses:
[email protected]

Total Funding:
1.37 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Content Delivery Network Google Universal Analytics Microsoft Exchange Online Office 365 Mail


Similar Organizations

aerial-biopharma-logo

Aerial BioPharma

Aerial BioPharma is a biopharmaceutical company developing biologics and small molecules for central nervous system issues.

anavex-logo

Anavex

Anavex is a biopharmaceutical company developing drugs for the treatment of cancer and neurological diseases.

apexigen-logo

Apexigen

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

aprecia-pharmaceuticals-logo

Aprecia Pharmaceuticals

Aprecia Pharmaceuticals develops precision drug delivery systems and products.

ataxion-logo

Ataxion

Ataxion is a discovery-stage biopharmaceutical company developing novel therapies for rare, debilitating, and underserved neurologic.

atriva-therapeutics-logo

Atriva Therapeutics

Atriva is a biopharmaceutical company which aims to develop new antiviral therapies against different respiratory viral infections.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

cure-pharmaceutical-logo

Cure Pharmaceutical

Cure Pharmaceutical is a specialty pharmaceutical and bioscience company, develops drug formulation and delivery technologies.

emerald-health-pharmaceuticals-logo

Emerald Health Pharmaceuticals

EHP is a biotech company developing biotechnology and cannabinoids science and technology to treat incurable diseases.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

euthymics-bioscience-logo

Euthymics Bioscience

Euthymics Bioscience, a neuroscience-focused biopharmaceutical company, develops medicines for central nervous system disorders.

genelux-logo

Genelux

Genelux, a clinical-stage biopharmaceutical company, develops diagnostic and therapeutic solutions for cancer and inflammatory diseases.

kechow-pharma-logo

KeChow Pharma

KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.

lumos-pharma-logo

Lumos Pharma

Lumos Pharma is a biopharmaceutical company that develops a novel treatment for the rare disease Creatine Transporter Deficiency.

maia-pharmaceuticals-logo

MAIA Pharmaceuticals

MAIA Pharmaceuticals identifies, develops, manufactures and markets innovative and niche generic products.

newbridge-pharmaceuticals-logo

NewBridge Pharmaceuticals

Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.

periphagen-logo

PeriphaGen

PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products.

regeneron-logo

Regeneron

Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.

regenerx-logo

RegeneRx

RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.

relypsa-logo

Relypsa

Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.

reneo-pharmaceuticals-logo

Reneo Pharmaceuticals

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

samsara-therapeutics-logo

Samsara Therapeutics

Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.

selecta-biosciences-logo

Selecta Biosciences

Selecta Biosciences is a clinical-stage biotechnology company with an unrelenting commitment to overcoming immunogenicity.

springworks-therapeutics-logo

SpringWorks Therapeutics

SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.

synaptogenix-logo

Synaptogenix

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

taurx-pharmaceuticals-logo

TauRx Pharmaceuticals

TauRx Pharmaceuticals is a life sciences company developing drugs and diagnostics for neurodegenerative diseases.

trevena-logo

Trevena

Trevena is a clinical stage biopharmaceutical company discovering and developing G-protein coupled receptors (GPCR) biased ligands.

wren-therapeutics-logo

Wren Therapeutics

Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.


Current Advisors List

jack-nielsen_image

Jack Nielsen Member of the Board of Directors @ Reata Pharmaceuticals
Board_member

dennis-keith-stone_image

Dennis Keith Stone Board of Directors @ Reata Pharmaceuticals
Board_member

not_available_image

Nancy Wysenski Member of the Board of Directors @ Reata Pharmaceuticals
Board_member

Current Employees Featured

dawn-c-bir_image

Dawn C. Bir
Dawn C. Bir Chief Commercial Officer & Executive Vice President @ Reata Pharmaceuticals
Chief Commercial Officer & Executive Vice President

colin-meyer_image

Colin Meyer
Colin Meyer Chief Medical Officer & Executive Vice President, Product Development @ Reata Pharmaceuticals
Chief Medical Officer & Executive Vice President, Product Development

manmeet-s-soni_image

Manmeet S. Soni
Manmeet S. Soni Chief Financial Officer @ Reata Pharmaceuticals
Chief Financial Officer
2019-08-01

michael-wortley_image

Michael Wortley
Michael Wortley Chief Legal Officer @ Reata Pharmaceuticals
Chief Legal Officer

not_available_image

Vinny Jindal
Vinny Jindal Vice President Strategy @ Reata Pharmaceuticals
Vice President Strategy
2016-11-01

manmeet-s-soni_image

Manmeet S. Soni
Manmeet S. Soni Chief Operating Officer @ Reata Pharmaceuticals
Chief Operating Officer
2020-06-01

warren-huff_image

Warren Huff
Warren Huff CEO @ Reata Pharmaceuticals
CEO
2002-09-01

Founder


warren-huff_image

Warren Huff

Stock Details


Company's stock symbol is NASDAQ:RETA

Investors List

blackstone-life-science_image

Blackstone Life Sciences

Blackstone Life Sciences investment in Post-IPO Equity - Reata Pharmaceuticals

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Reata Pharmaceuticals

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Reata Pharmaceuticals

novo-a-s_image

Novo Holdings

Novo Holdings investment in Venture Round - Reata Pharmaceuticals

cpmg_image

CPMG

CPMG investment in Venture Round - Reata Pharmaceuticals

novo-a-s_image

Novo Holdings

Novo Holdings investment in Series E - Reata Pharmaceuticals

cpmg_image

CPMG

CPMG investment in Series E - Reata Pharmaceuticals

startech-early-ventures_image

Startech Early Ventures

Startech Early Ventures investment in Series D - Reata Pharmaceuticals

ojai-goliad_image

Ojai Goliad

Ojai Goliad investment in Series D - Reata Pharmaceuticals

cardinal-investment-co_image

Cardinal Investment Co.

Cardinal Investment Co. investment in Series D - Reata Pharmaceuticals

Official Site Inspections

http://www.reatapharma.com Semrush global rank: 2.86 M Semrush visits lastest month: 5.66 K

  • Host name: server-3-167-88-93.iad55.r.cloudfront.net
  • IP address: 3.167.88.93
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Reata Pharmaceuticals"

Reata Pharmaceuticals, Inc. | LinkedIn

Reata Pharmaceuticals, Inc. | 23,251 followers on LinkedIn. Changing the landscape in life-threatening diseases | Reata Pharmaceuticals has been acquired by Biogen. Please follow …See details»

Overview, News & Similar companies - ZoomInfo.com

Jan 23, 2024 View Reata Pharmaceuticals (www.reatapharma.com) location in Texas, United States , revenue, industry and description. Find related and similar companies as well as …See details»

Reata Pharmaceuticals - Wikipedia

Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, it is primarily focused on investigating experimental oral antioxidative and anti …See details»

Reata Pharmaceuticals | Biogen

Reata Pharmaceuticals has been acquired by Biogen.Disease Areas Alzheimer's Disease Amyotrophic Lateral Sclerosis Friedreich Ataxia Kidney Disease Lupus Multiple Sclerosis …See details»

Reata Pharmaceuticals Inc Company Profile - GlobalData

Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company. It develops innovative medicines for the treatment of serious and life-threatening diseases. The …See details»

Reata Pharmaceuticals - Craft

Sep 26, 2023 Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases. It targets molecular …See details»

Reata Pharmaceuticals Company Overview, Contact Details

May 10, 2023 Learn more about Reata Pharmaceuticals's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

@ReataPharma | X

The latest posts from @ReataPharmaSee details»

Reata Pharmaceuticals - Profiles & Contacts - Crunchbase

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.See details»

Reata Pharmaceuticals: Revenue, Worth, Valuation & Competitors …

Reata Pharmaceuticals powers ahead with estimated revenue of $53.6M, team of around 400+ employees, working out of Irving, building on operational efficiency.See details»

Reata Pharmaceuticals, Inc. Company Overview, Contact Details ...

May 10, 2023 Learn more about Reata Pharmaceuticals, Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a …See details»

Working at Reata Pharmaceuticals - Zippia

Find out what it's like to work at Reata Pharmaceuticals. See what kind of people work at Reata Pharmaceuticals, career paths working at Reata Pharmaceuticals, company culture, salaries, …See details»

Reata Pharmaceuticals, Inc. - Org Chart | BizKonnect

Explore Reata Pharmaceuticals, Inc. org chart. You can order an account map which is a customized organization chart with relevant insights and contact information.See details»

Reata Pharmaceuticals | Biogen

Reata Pharmaceuticals has been acquired by Biogen.See details»

Reata Pharmaceuticals CEO and Key Executive Team - Craft.co

Reata Pharmaceuticals's Founding Chief Executive Officer and President, Director is Warren Huff. Reata Pharmaceuticals's key executives include Warren Huff and 17 others.See details»

MitoWorld

Since its founding in 2002, Reata has been leading the dawn of a new era in pharmaceutical approaches for the treatment of serious and life-threatening diseases. We are dedicated to …See details»

Reata Pharmaceuticals 2025 Company Profile: Valuation

Information on acquisition, funding, cap tables, investors, and executives for Reata Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

Reata Pharmaceuticals Company Profile | Management and

Reata Pharmaceuticals Profile and History Founded in 2002, Reata Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or …See details»

Reata Pharmaceuticals - Financial Details - Crunchbase

Jul 12, 2025 Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.See details»

Reata Pharmaceuticals CEO, Founder, Key Executive Team, Board …

Explore {Reata Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

linkstock.net © 2022. All rights reserved